Browse by Journal Title

2023

Protease-activated receptor-1 IgG autoantibodies in patients with COVID-19.
Reinshagen, L. and Nageswaran, V. and Heidecke, H. and Schulze-Forster, K. and Wilde, A.C.B. and Ramezani Rad, P. and Poller, W. and Asmus, E. and Simmons, S. and Kuebler, W.M. and Witzenrath, M. and Marko, L. and Jakobs, K. and Leistner, D.M. and Rauch-Kröhnert, U. and Kränkel, N. and Forslund, S.K. and Landmesser, U. and Müller, D.N. and Haghikia, A.
Thrombosis and Haemostasis 6 November 2023 (In Press)

2020

Interruption of the CXCL13/CXCR5 chemokine axis enhances plasma IgM levels and attenuates atherosclerosis development.
van der Vorst, E.P.C. and Daissormont, I. and Aslani, M. and Seijkens, T. and Wijnands, E. and Lutgens, E. and Duchene, J. and Santovito, D. and Döring, Y. and Halvorsen, B. and Aukrust, P. and Weber, C. and Höpken, U.E. and Biessen, E.A.L.
Thrombosis and Haemostasis 120 (2): 344-347. February 2020

2007

Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII.
Sarafanov, A.G. and Makogonenko, E.M. and Andersen, O.M. and Mikhailenko, I.A. and Ananyeva, N.M. and Khrenov, A.V. and Shima, M. and Strickland, D.K. and Saenko, E.L.
Thrombosis and Haemostasis 98 (6): 1170-1181. December 2007

Intraoperative fresh-frozen plasma versus human albumin in craniofacial surgery - a pilot study comparing coagulation profiles in infants younger than 12 months.
Hildebrandt, B. and Machotta, A. and Riess, H. and Kerner, S. and Ahlers, O. and Haberl, H. and Doerken, B. and Kerner, T.
Thrombosis and Haemostasis 98 (1): 172-7. July 2007

2006

Thrombospondin-4 Ala387Pro polymorphism is not associated with vascular function and risk of coronary heart disease in US men and women.
Asselbergs, F.W. and Pai, J.K. and Pischon, T. and Manson, J.E. and Rimm, E.B.
Thrombosis and Haemostasis 95 (3): 589-590. March 2006

2005

Effect of surface modified liposomes on the aggregation of platelets and tumor cells.
Keil, C. and Zeisig, R. and Fichtner, I.
Thrombosis and Haemostasis 94 (2): 404-411. August 2005

2003

Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway.
Kiian, I. and Tkachuk, N. and Haller, H. and Dumler, I.
Thrombosis and Haemostasis 89 (5): 904-914. May 2003

1999

Ventricular remodeling after acute myocardial infarction.
Dietz, R. and Osterziel, K.J. and Willenbrock, R. and Gulba, D.C. and von Harsdorf, R.
Thrombosis and Haemostasis 82 (Suppl 1): 73-75. September 1999

Treatment of carotid artery stenosis by elective stent placement instead of carotid endarterectomy in patients with severe coronary artery disease.
Gross, C.M. and Kraemer, J. and Uhlich, F. and Tamaschke, C. and Vogel, P. and Friedrich, I. and Dietz, R. and Waigand, J.
Thrombosis and Haemostasis 82 (Suppl 1): 176-180. September 1999

Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach.
Gulba, D.C.
Thrombosis and Haemostasis 82 (2): 953-961. August 1999

Transcriptional regulation of the murine urokinase-type plasminogen activator gene in skeletal myoblasts.
Miralles, F. and Ibanez-Tallon, I. and Parra, M. and Crippa, M. and Blasi, F. and Besser, D. and Nagamine, Y. and Munoz-Canoves, P.
Thrombosis and Haemostasis 81 (5): 767-774. May 1999

1995

Sulfated polysaccharide anticoagulants suppress natural killer cell activity in vitro.
Johann, S. and Zoller, C. and Haas, S. and Bluemel, G. and Lipp, M. and Foerster, R.
Thrombosis and Haemostasis 74 (4): 998-1002. October 1995

1992

Characterization of human tissue-type plasminogen activator with monoclonal antibodies - mapping of epitopes and binding sites for fibrin and lysine.
Zacharias, U. and Fischer, B. and Noll, F. and Will, H.
Thrombosis and Haemostasis 67 (1): 88-94. 23 January 1992